share_log

Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month

Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month

本月可能挽救您的投資組合的兩大醫療保健股票
Benzinga ·  04/23 20:36

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

醫療保健領域超賣次數最多的股票爲買入被低估的公司提供了機會。

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

RSI是一個動量指標,它比較股票在價格上漲的日子裏的走強與價格下跌的日子的走強。與股票的價格走勢相比,它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據,當相對強弱指數低於30時,資產通常被視爲超賣。

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

以下是該行業主要超賣參與者的最新名單,RSI接近或低於30。

MultiPlan Corporation (NYSE:MPLN)

MultiPlan 公司(紐約證券交易所代碼:MPLN)

  • On April 16, MultiPlan said it will release its first quarter 2024 financial results on Wednesday, May 8, 2024. The company's stock fell around 18% over the past five days and has a 52-week low of $0.55.
  • RSI Value: 28.54
  • MPLN Price Action: Shares of MultiPlan dipped 14.9% to close at $0.5532 on Monday.
  • 4月16日,MultiPlan表示將於2024年5月8日星期三發佈其2024年第一季度財務業績。該公司的股票在過去五天中下跌了約18%,跌至52周低點0.55美元。
  • RSI 值:28.54
  • MPLN價格走勢:週一,MultiPlan的股價下跌14.9%,收於0.5532美元。

Agenus Inc. (NASDAQ:AGEN)

Agenus Inc.(納斯達克股票代碼:AGEN)

  • On April 12, Agenus released updated results from its Phase 1 clinical trial of botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic colorectal cancer (CRC) that is not microsatellite instability-high (MSS) or deficient mismatch repair (dMMR). The company's stock fell around 48% over the past month. It has a 52-week low of $4.78.
  • RSI Value: 28.59
  • AGEN Price Action: Shares of Agenus gained 8.7% to close at $5.77 on Monday.
  • 4月12日,Agenus發佈了其針對轉移性結直腸癌(CRC)的botensilimab和balstilimab(BOT/BAL)聯合療法的1期臨床試驗的最新結果,該療法不是微衛星不穩定性高(MSS)或缺陷失配修復(dmMR)。該公司的股票在過去一個月中下跌了約48%。它 創下 52 周低點 爲4.78美元。
  • RSI 值:28.59
  • AGEN價格走勢:週一,Agenus的股價上漲8.7%,收於5.77美元。

Read More: General Motors, Tesla And 3 Stocks To Watch Heading Into Tuesday

閱讀更多:通用汽車、特斯拉和三隻股票在週二值得關注

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論